Brussels, 20 January 2025
EuropaBio calls for an ambitious cross-sectoral EU Biotech Act, that strengthens Europe as a global biotechnology leader for competitiveness and strategic autonomy.

The association, which represents bioindustries across ecosystems, pitches for an Act which strengthens value chains from R&D to end-users, creates coherent regulatory pathways and builds a next-generation ecosystem. The three-pillar approach proposes faster financing mechanisms, simpler regulatory and operational frameworks, plus strong, connected and skilled value chains.

Dr Claire Skentelbery, Director General of EuropaBio commented “The EU Biotech Act is Europe’s opportunity to create a cornerstone for this strategically critical technology. It is vital that biotech is recognised at a high policy level, and a strong Biotech Act sends a global signal that our innovation and capacity will support healthy citizens, competitive sectors and a sustainable future.”

EuropaBio looks forward to engaging with stakeholders to shape a bold and impactful Act as part of a broader legislative cluster supporting the integration and impact of biotechnology.